Amira Barkal

Amira Barkal is a Clinical Fellow in Medicine at Brigham and Women’s Hospital at Harvard Medical School. She earned her MD and PhD degrees from Stanford University School of Medicine in 2021 as part of the Medical Scientist Training Program, where she led the discovery of CD24 as a novel innate immune checkpoint in cancer. Dr. Barkal is an expert in cancer immune evasion pathways as well as regulators of macrophage function. She is a recipient of the Ruth L. Kirschstein Fellowship of the National Cancer Institute, the Harold M. Weintraub Award, and the Society of Immunotherapy of Cancer Young Investigator Award.